# BEL Fuse Inc: financial statements, quarterly

BELFA · Nasdaq · CIK 729580 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/belfa.md) · [Financials](/companies/belfa/financials.md) · [Filings](/companies/belfa/filings.md) · [Insiders](/companies/belfa/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/belfa/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [159](/filings/0001437749-24-032429.md) | [140 d](/filings/0001437749-26-005354.md) | [128](/filings/0001437749-25-014041.md) | [133](/filings/0001437749-25-024168.md) | [124](/filings/0001437749-25-032940.md) | [150 d](/filings/0001437749-26-005354.md) | [152](/filings/0001437749-26-014903.md) | [168](/filings/0001437749-26-025619.md) | [179](/filings/0001437749-25-032940.md) | [176 d](/filings/0001437749-26-005354.md) | [178](/filings/0001437749-26-014903.md) | [211](/filings/0001437749-26-025619.md) |
| Cost of revenue | $m | [103](/filings/0001437749-24-032429.md) | [88.8 d](/filings/0001437749-26-005354.md) | [80.0](/filings/0001437749-25-014041.md) | [79.8](/filings/0001437749-25-024168.md) | [79.0](/filings/0001437749-25-032940.md) | [93.7 d](/filings/0001437749-26-005354.md) | [93.4](/filings/0001437749-26-014903.md) | [103](/filings/0001437749-26-025619.md) | [108](/filings/0001437749-25-032940.md) | [107 d](/filings/0001437749-26-005354.md) | [109](/filings/0001437749-26-014903.md) | [127](/filings/0001437749-26-025619.md) |
| Gross profit | $m | [55.5](/filings/0001437749-24-032429.md) | [51.2 d](/filings/0001437749-26-005354.md) | [48.1](/filings/0001437749-25-014041.md) | [53.4](/filings/0001437749-25-024168.md) | [44.7](/filings/0001437749-25-032940.md) | [56.2 d](/filings/0001437749-26-005354.md) | [58.8](/filings/0001437749-26-014903.md) | [65.1](/filings/0001437749-26-025619.md) | [71.1](/filings/0001437749-25-032940.md) | [69.4 d](/filings/0001437749-26-005354.md) | [69.6](/filings/0001437749-26-014903.md) | [84.0](/filings/0001437749-26-025619.md) |
| Research and development | $m | [5.3](/filings/0001437749-24-032429.md) | [6.0 d](/filings/0001437749-26-005354.md) | [5.2](/filings/0001437749-25-014041.md) | [6.0](/filings/0001437749-25-024168.md) | [5.4](/filings/0001437749-25-032940.md) | [6.9 d](/filings/0001437749-26-005354.md) | [7.2](/filings/0001437749-26-014903.md) | [8.1](/filings/0001437749-26-025619.md) | [7.5](/filings/0001437749-25-032940.md) | [8.0 d](/filings/0001437749-26-005354.md) | [8.5](/filings/0001437749-26-014903.md) | [9.0](/filings/0001437749-26-025619.md) |
| Selling, general and administrative | $m | [23.7](/filings/0001437749-24-032429.md) | [24.9 d](/filings/0001437749-26-005354.md) | [24.9](/filings/0001437749-25-014041.md) | [24.1](/filings/0001437749-25-024168.md) | [26.7](/filings/0001437749-25-032940.md) | [34.8 d](/filings/0001437749-26-005354.md) | [29.5](/filings/0001437749-26-014903.md) | [30.9](/filings/0001437749-26-025619.md) | [32.8](/filings/0001437749-25-032940.md) | [32.6 d](/filings/0001437749-26-005354.md) | [36.7](/filings/0001437749-26-014903.md) | [36.3](/filings/0001437749-26-025619.md) |
| Operating income | $m | [24.5](/filings/0001437749-24-032429.md) | [16.5 d](/filings/0001437749-26-005354.md) | [17.9](/filings/0001437749-25-014041.md) | [22.6](/filings/0001437749-25-024168.md) | [11.4](/filings/0001437749-25-032940.md) | [12.4 d](/filings/0001437749-26-005354.md) | [25.0](/filings/0001437749-26-014903.md) | [29.9](/filings/0001437749-26-025619.md) | [30.3](/filings/0001437749-25-032940.md) | [25.8 d](/filings/0001437749-26-005354.md) | [23.7](/filings/0001437749-26-014903.md) | [38.4](/filings/0001437749-26-025619.md) |
| Interest expense | $m | [0.5](/filings/0001437749-24-032429.md) | [0.4 d](/filings/0001437749-24-007265.md) | [0.4](/filings/0001437749-25-014041.md) | [0.4](/filings/0001437749-25-024168.md) | [0.4](/filings/0001437749-25-032940.md) | [2.8 d](/filings/0001437749-26-005354.md) | [4.2](/filings/0001437749-25-014041.md) | [4.0](/filings/0001437749-25-024168.md) | [3.6](/filings/0001437749-25-032940.md) | [3.0 d](/filings/0001437749-26-005354.md) | [2.5](/filings/0001437749-26-014903.md) | [1.8](/filings/0001437749-26-025619.md) |
| Income tax | $m | [4.3](/filings/0001437749-24-032429.md) | [1.5 d](/filings/0001437749-26-005354.md) | [4.5](/filings/0001437749-25-014041.md) | [4.1](/filings/0001437749-25-024168.md) | [3.1](/filings/0001437749-25-032940.md) | [1.0 d](/filings/0001437749-26-005354.md) | [5.5](/filings/0001437749-26-014903.md) | [6.9](/filings/0001437749-26-025619.md) | [5.4](/filings/0001437749-25-032940.md) | [3.1 d](/filings/0001437749-26-005354.md) | [2.8](/filings/0001437749-26-014903.md) | [3.8](/filings/0001437749-26-025619.md) |
| Net income | $m | [19.4](/filings/0001437749-24-032429.md) | [12.0 d](/filings/0001437749-26-005354.md) | [15.9](/filings/0001437749-25-014041.md) | [18.8](/filings/0001437749-24-032429.md) | [8.1](/filings/0001437749-24-032429.md) | [(1.8) d](/filings/0001437749-26-005354.md) | [17.9](/filings/0001437749-26-025619.md) | [26.9](/filings/0001437749-26-025619.md) | [22.6](/filings/0001437749-25-032940.md) | [(6.1) d](/filings/0001437749-26-005354.md) | [11.4](/filings/0001437749-26-025619.md) | [25.5](/filings/0001437749-26-025619.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [100](/filings/0001437749-23-030168.md) | [89.4](/filings/0001437749-25-005652.md) | [71.3](/filings/0001437749-24-013891.md) | [85.0](/filings/0001437749-24-024020.md) | [134](/filings/0001437749-24-032429.md) | [68.3](/filings/0001437749-26-005354.md) | [65.9](/filings/0001437749-25-014041.md) | [59.3](/filings/0001437749-25-024168.md) | [57.7](/filings/0001437749-25-032940.md) | [57.8](/filings/0001437749-26-025619.md) | [59.4](/filings/0001437749-26-014903.md) | [306](/filings/0001437749-26-025619.md) |
| Current assets | $m | [363](/filings/0001437749-23-030168.md) | [381](/filings/0001437749-25-005652.md) | [364](/filings/0001437749-24-013891.md) | [376](/filings/0001437749-24-024020.md) | [388](/filings/0001437749-24-032429.md) | [374](/filings/0001437749-26-005354.md) | [368](/filings/0001437749-25-014041.md) | [379](/filings/0001437749-25-024168.md) | [388](/filings/0001437749-25-032940.md) | [385](/filings/0001437749-26-025619.md) | [397](/filings/0001437749-26-014903.md) | [699](/filings/0001437749-26-025619.md) |
| Total assets | $m | [559](/filings/0001437749-23-030168.md) | [572](/filings/0001437749-26-005354.md) | [555](/filings/0001437749-25-014041.md) | [568](/filings/0001437749-25-024168.md) | [584](/filings/0001437749-25-032940.md) | [950](/filings/0001437749-26-005354.md) | [584](/filings/0001437749-26-014903.md) | [951](/filings/0001437749-26-025619.md) | [953](/filings/0001437749-25-032940.md) | [935](/filings/0001437749-26-025619.md) | [952](/filings/0001437749-26-014903.md) | [1,264](/filings/0001437749-26-025619.md) |
| Current liabilities | $m | [118](/filings/0001437749-23-030168.md) | [111](/filings/0001437749-25-005652.md) | [86.5](/filings/0001437749-24-013891.md) | [89.8](/filings/0001437749-24-024020.md) | [96.9](/filings/0001437749-24-032429.md) | [128](/filings/0001437749-26-005354.md) | [111](/filings/0001437749-25-014041.md) | [124](/filings/0001437749-25-024168.md) | [127](/filings/0001437749-25-032940.md) | [127](/filings/0001437749-26-025619.md) | [125](/filings/0001437749-26-014903.md) | [156](/filings/0001437749-26-025619.md) |
| Total liabilities | $m | [238](/filings/0001437749-23-030168.md) | [231](/filings/0001437749-25-005652.md) | [209](/filings/0001437749-24-013891.md) | [211](/filings/0001437749-24-024020.md) | [217](/filings/0001437749-24-032429.md) | [509](/filings/0001437749-26-005354.md) | [483](/filings/0001437749-25-014041.md) | [465](/filings/0001437749-25-024168.md) | [444](/filings/0001437749-25-032940.md) | [417](/filings/0001437749-26-025619.md) | [416](/filings/0001437749-26-014903.md) | [252](/filings/0001437749-26-025619.md) |
| Long-term debt | $m | [60.0](/filings/0001437749-23-030168.md) | [60.0](/filings/0001437749-25-005652.md) | [60.0](/filings/0001437749-24-013891.md) | [60.0](/filings/0001437749-24-024020.md) | [60.0](/filings/0001437749-24-032429.md) | [288](/filings/0001437749-26-005354.md) | [280](/filings/0001437749-25-014041.md) | [250](/filings/0001437749-25-024168.md) | [225](/filings/0001437749-25-032940.md) | [198](/filings/0001437749-26-025619.md) | [205](/filings/0001437749-26-014903.md) | [0.0](/filings/0001437749-26-025619.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [321](/filings/0001437749-24-032429.md) | [341](/filings/0001437749-25-005652.md) | [347](/filings/0001437749-24-032429.md) | [356](/filings/0001437749-24-032429.md) | [367](/filings/0001437749-24-032429.md) | [361](/filings/0001437749-26-005354.md) | [377](/filings/0001437749-25-014041.md) | [405](/filings/0001437749-25-024168.md) | [428](/filings/0001437749-25-032940.md) | [426](/filings/0001437749-26-025619.md) | [439](/filings/0001437749-26-014903.md) | [909](/filings/0001437749-26-025619.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [40.8 d](/filings/0001437749-24-032429.md) | [26.9 d](/filings/0001437749-26-005354.md) | [6.2](/filings/0001437749-25-014041.md) | [32.2 d](/filings/0001437749-25-024168.md) | [27.4 d](/filings/0001437749-25-032940.md) | [8.3 d](/filings/0001437749-26-005354.md) | [8.1](/filings/0001437749-26-014903.md) | [20.7 d](/filings/0001437749-26-025619.md) | [22.2 d](/filings/0001437749-25-032940.md) | [29.6 d](/filings/0001437749-26-005354.md) | [13.8](/filings/0001437749-26-014903.md) | [17.9 d](/filings/0001437749-26-025619.md) |
| Capital expenditure | $m | [2.6 d](/filings/0001437749-24-032429.md) | [2.5 d](/filings/0001437749-26-005354.md) | [2.9](/filings/0001437749-25-014041.md) | [1.3 d](/filings/0001437749-25-024168.md) | [3.6 d](/filings/0001437749-25-032940.md) | [6.2 d](/filings/0001437749-26-005354.md) | [2.8](/filings/0001437749-26-014903.md) | [3.9 d](/filings/0001437749-26-025619.md) | [1.9 d](/filings/0001437749-25-032940.md) | [3.4 d](/filings/0001437749-26-005354.md) | [2.6](/filings/0001437749-26-014903.md) | [2.2 d](/filings/0001437749-26-025619.md) |
| Dividends paid | $m | [0.8 d](/filings/0001437749-24-032429.md) | [1.0 d](/filings/0001437749-26-005354.md) | [0.8](/filings/0001437749-25-014041.md) | [0.8 d](/filings/0001437749-25-024168.md) | [0.8 d](/filings/0001437749-25-032940.md) | [1.0 d](/filings/0001437749-26-005354.md) | [0.8](/filings/0001437749-26-014903.md) | [0.8 d](/filings/0001437749-26-025619.md) | [0.8 d](/filings/0001437749-25-032940.md) | [1.0 d](/filings/0001437749-26-005354.md) | [0.8](/filings/0001437749-26-014903.md) | [0.8 d](/filings/0001437749-26-025619.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-032429.md) | [0.1 d](/filings/0001437749-26-005354.md) | [6.3](/filings/0001437749-25-014041.md) | [7.9 d](/filings/0001437749-25-024168.md) | [1.9 d](/filings/0001437749-25-032940.md) | [0.0 d](/filings/0001437749-26-005354.md) | [0.0](/filings/0001437749-25-014041.md) | [0.0 d](/filings/0001437749-25-024168.md) | [0.0 d](/filings/0001437749-25-032940.md) | [0.0 d](/filings/0001437749-26-005354.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 2,174,912 at 2011-08-01, from the cover of the [10-Q/A filed 2011-08-09](/filings/0000729580-11-000026.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.